Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001615219-22-000087)

Filing Details

Accession Number:: 0001615219-22-000087
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-05-31 17:17:24
Reporting Period:: 2022-05-26

Accepted Time:: 2022-05-31 17:17:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1615219	Salarius Pharmaceuticals Inc.	SLRX	Pharmaceutical Preparations (2834)	465087339

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1769331	J. David Arthur	C/O Salarius Pharmaceuticals, Inc. 2450 Holcome Blvd., Suite X Houston TX 77021	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-05-26	3,400	$0.18	263,074	No	4	P	Direct
Common Stock	Acquisiton	2022-05-26	18,600	$0.18	281,674	No	4	P	Direct
Common Stock	Acquisiton	2022-05-26	708	$0.18	282,382	No	4	P	Indirect	By son
Common Stock	Acquisiton	2022-05-26	10,392	$0.18	292,774	No	4	P	Indirect	By son
Common Stock	Acquisiton	2022-05-26	10,800	$0.18	303,574	No	4	P	Indirect	By daughter

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Indirect	By son
No	4	P	Indirect	By son
No	4	P	Indirect	By daughter

Footnotes

The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.